Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Feb 28, 2016; 22(8): 2576-2584
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2576
Table 4 Association between increased serum direct bilirubin level and clinicopathological data n (%)
VariableDirect bilirubin2.60μmol/LDirect bilirubin < 2.60μmol/LP value
Gender
Male148 (70.5)138 (53.3)< 0.001
Female62 (29.5)121 (46.7)-
Age, yr
< 6079 (37.6)102 (39.4)0.697
≥ 60131 (62.4)157 (60.6)-
Serum sodium, mmol/L
≤ 141101 (49.5)142 (56.1)0.159
> 141103 (50.5)111 (43.9)-
Carcinoembryonic antigen, ng/mL
< 5.085 (50.0)129 (58.1)0.110
≥ 5.085 (50.0)93 (41.9)-
Tumor differentiation
Moderately/well171 (86.8)217 (87.5)0.827
Poorly26 (13.2)31 (12.5)-
Pathological tumor classification (pT)
pT1/ pT239 (18.6)69 (26.6)0.039
pT3/ pT4171 (81.4)190 (73.4)-
Pathological lymph node stage (pN)
pN165 (57.0)71 (60.7)0.571
pN249 (43.0)46 (39.3)-
Pathological distant metastasis (pM)
pM0200 (95.2)239 (92.3)0.193
pM110 (4.8)20 (7.7)-